Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Benjamin D Horne, Rehan Ali, Dawn Midwinter, Catherine Scott-Wilson, Courtney Crim, Bruce E Miller & David B Rubin. (2021) Validation of the Summit Lab Score in Predicting Exacerbations of Chronic Obstructive Pulmonary Disease Among Individuals with High Arterial Stiffness. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 41-51.
Read now
Read now
Wilhelmine H Meeraus, Hana Mullerova, Céline El Baou, Marion Fahey, Edith M Hessel & William A Fahy. (2021) Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 225-244.
Read now
Read now
Konstantinos Kostikas, Alexander J Mackay, Claus F Vogelmeier, Stefan-Marian Frent, Pritam Gupta, Donald Banerji, Francesco Patalano, Pascal J Pfister & Jadwiga A Wedzicha. (2020) Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1831-1838.
Read now
Read now
Zhendong Jiang, Youming Huang, Hui Jiang, Ping Wang, Lei Zhang, Li Ren & Ping Han. (2020) Albuterol combined with tiotropium bromide to improve the conditions and pulmonary functions of patients with acute exacerbation of chronic obstructive pulmonary disease. All Life 13:1, pages 668-674.
Read now
Read now
Anthony C A Yii, CH Loh, PY Tiew, Huiying Xu, Aza A M Taha, Jansen Koh, Jessica Tan, Therese S Lapperre, Antonio Anzueto & Augustine K H Tee. (2019) A clinical prediction model for hospitalized COPD exacerbations based on “treatable traits”. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 719-728.
Read now
Read now
Wei-ping Hu, Tsokyi Lhamo, Dong Liu, Jing-qing Hang, Feng-ying Zhang, Yi-hui Zuo, Ying-ying Zeng & Jing Zhang. (2019) Development of a Nomogram to Predict the Risk of 30-Day Re-Exacerbation for Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:2, pages 160-167.
Read now
Read now
Bertrand Herer & Thierry Chinet. (2018) Acute exacerbation of COPD during pulmonary rehabilitation: outcomes and risk prediction. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1767-1774.
Read now
Read now
Peter MA Calverley, Kay Tetzlaff, Daniel Dusser, Robert A Wise, Achim Mueller, Norbert Metzdorf & Antonio Anzueto. (2017) Determinants of exacerbation risk in patients with COPD in the TIOSPIR study. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 3391-3405.
Read now
Read now
Martine Hoogendoorn, Talitha L Feenstra, Melinde Boland, Andrew H Briggs, Sixten Borg, Sven-Arne Jansson, Nancy A Risebrough, Julia F Slejko & Maureen PMH Rutten-van Mölken. (2017) Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 3183-3194.
Read now
Read now
Sofia Sveréus, Kjell Larsson & Clas Rehnberg. (2017) Clinic continuity of care, clinical outcomes and direct costs for COPD in Sweden: a population based cohort study. European Clinical Respiratory Journal 4:1.
Read now
Read now
Peter M Calverley, Dirkje S Postma, Antonio R Anzueto, Barry J Make, Göran Eriksson, Stefan Peterson & Christine R Jenkins. (2016) Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 381-390.
Read now
Read now
Magnus Ekström, Josefin Sundh & Kjell Larsson. (2016) Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use?. Expert Review of Respiratory Medicine 10:3, pages 351-362.
Read now
Read now
Marjan Kerkhof, Daryl Freeman, Rupert Jones, Alison Chisholm & David B Price. (2015) Predicting frequent COPD exacerbations using primary care data. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2439-2450.
Read now
Read now
Articles from other publishers (27)
John R. Hurst, MeiLan K. Han, Barinder Singh, Sakshi Sharma, Gagandeep Kaur, Enrico de Nigris, Ulf Holmgren & Mohd Kashif Siddiqui. (2022) Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review. Respiratory Research 23:1.
Crossref
Crossref
Siyang Zeng, Mehrdad Arjomandi & Gang Luo. (2022) Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study. JMIR Medical Informatics 10:2, pages e33043.
Crossref
Crossref
Siyang Zeng, Mehrdad Arjomandi, Yao Tong, Zachary C Liao & Gang Luo. (2022) Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study. Journal of Medical Internet Research 24:1, pages e28953.
Crossref
Crossref
Bo-Guen Kim, Sun Hye Shin, Hyun-Il Gil, Sungmin Zo, Yunjoo Im, Ju Yeun Song, Chai Young Lee, Danbee Kang, Juhee Cho & Hye Yun Park. (2022) Change in individual chronic obstructive pulmonary disease assessment test item scores after short-term bronchodilator therapy and its impact on exacerbation in treatment-naïve patients with chronic obstructive pulmonary disease. Therapeutic Advances in Chronic Disease 13, pages 204062232211142.
Crossref
Crossref
Simona Tabea Huebner, Simona Henny, Stéphanie Giezendanner, Thomas Brack, Martin Brutsche, Prashant Chhajed, Christian Clarenbach, Thomas Dieterle, Adrian Egli, Martin Frey, Ingmar Heijnen, Sarosh Irani, Noriane Andrina Sievi, Robert Thurnheer, Marten Trendelenburg, Malcolm Kohler, Anne Barbara Leuppi-Taegtmeyer & Joerg Daniel Leuppi. (2022) Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers. Respiration 101:5, pages 441-454.
Crossref
Crossref
Gang Luo, Bryan L Stone, Xiaoming Sheng, Shan He, Corinna Koebnick & Flory L Nkoy. (2021) Using Computational Methods to Improve Integrated Disease Management for Asthma and Chronic Obstructive Pulmonary Disease: Protocol for a Secondary Analysis. JMIR Research Protocols 10:5, pages e27065.
Crossref
Crossref
V Amelia, T Siswantining & T Kamelia. (2021) Prediction model of exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD) at RSCM. Journal of Physics: Conference Series 1725:1, pages 012011.
Crossref
Crossref
Agnieszka Król, Robert Palmér, Virginie Rondeau, Stephen Rennard, Ulf G. Eriksson & Alexandra Jauhiainen. (2020) Improving the evaluation of COPD exacerbation treatment effects by accounting for early treatment discontinuations: a post-hoc analysis of randomized clinical trials. Respiratory Research 21:1.
Crossref
Crossref
Pascal Urwyler, Nebal Abu Hussein, Pierre O. Bridevaux, Prashant N. Chhajed, Thomas Geiser, Peter Grendelmeier, Ladina Joos Zellweger, Malcolm Kohler, Sabrina Maier, David Miedinger, Michael Tamm, Robert Thurnheer, Thomas Dieterle & Joerg D. Leuppi. (2019) Predictive factors for exacerbation and re-exacerbation in chronic obstructive pulmonary disease: an extension of the Cox model to analyze data from the Swiss COPD cohort. Multidisciplinary Respiratory Medicine 14:1.
Crossref
Crossref
Rahul Gondalia, Bruce G. Bender, Benjamin Theye & David A. Stempel. (2019) Higher short-acting beta-agonist use is associated with greater COPD burden. Respiratory Medicine 158, pages 110-113.
Crossref
Crossref
Jongmin Lee, Hyun Myung Jung, Sook Kyung Kim, Kwang Ha Yoo, Ki-Suck Jung, Sang Haak Lee & Chin Kook Rhee. (2019) Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis. Scientific Reports 9:1.
Crossref
Crossref
Xiang Zhong, Sujee Lee, Cong Zhao, Hyo Kyung Lee, Philip A. Bain, Tammy Kundinger, Craig Sommers, Christine Baker & Jingshan Li. (2017) Reducing COPD readmissions through predictive modeling and incentive-based interventions. Health Care Management Science 22:1, pages 121-139.
Crossref
Crossref
Richard H. StanfordMatthew S. LauYong LiStephen Stemkowski. (2019) External Validation of a COPD Risk Measure in a Commercial and Medicare Population: The COPD Treatment Ratio. Journal of Managed Care & Specialty Pharmacy 25:1, pages 58-69.
Crossref
Crossref
Sujee Lee, Sijie Wang, Philip A. Bain, Tammy Kundinger, Craig Sommers, Christine Baker & Jingshan Li. (2019) Modeling and Analysis of Postdischarge Intervention Process to Reduce COPD Readmissions. IEEE Transactions on Automation Science and Engineering 16:1, pages 21-34.
Crossref
Crossref
Feruza Turan Sönmez & Recep Eröz. (2018) The role of argyrophilic nucleolar organizing region-associated proteins in clinical exacerbation of chronic obstructive pulmonary disease. Journal of International Medical Research 46:12, pages 4995-5003.
Crossref
Crossref
Daiana Stolz, Hans H. Hirsch, Daniel Schilter, Renaud Louis, Janko Rakic, Lucas Boeck, Eleni Papakonstantinou, Christian Schindler, Leticia Grize & Michael Tamm. (2018)
Reply to Palmer
et al.
: Does Dose Matter?
. American Journal of Respiratory and Critical Care Medicine 198:8, pages 1103-1105.
Crossref
Crossref
Kieran Palmer, Raja K. Rajakulasingam & Angshu Bhowmik. (2018) Does Dose Matter?. American Journal of Respiratory and Critical Care Medicine 198:8, pages 1102-1103.
Crossref
Crossref
Sujee Lee, Sijie Wang, Philip A. Bain, Christine Baker, Tammy Kundinger, Craig Sommers & Jingshan Li. (2018) Reducing COPD Readmissions: A Causal Bayesian Network Model. IEEE Robotics and Automation Letters 3:4, pages 4046-4053.
Crossref
Crossref
Nikolaos Tatsis, Sotirios Kakavas, Evgenios Metaxas, Evangelos Balis, George Tatsis, Nikolaos Pantazis, Petros Bakakos, Nikolaos Koulouris & Κostantinos Hadjistavrou. (2018) Spirometric Values of Greek People and Comparison with ECSC and GLI Values in COPD People. The Open Respiratory Medicine Journal 12:1, pages 29-38.
Crossref
Crossref
Robert M. Burkes, Amanda J. Gassett, Agathe S. Ceppe, Wayne Anderson, Wanda K. O’Neal, Prescott G. Woodruff, Jerry A. Krishnan, R. Graham Barr, MeiLan K. Han, Fernando J. Martinez, Alejandro P. Comellas, Allison A. Lambert, Joel D. Kaufman, Mark T. Dransfield, J. Michael Wells, Richard E. Kanner, Robert PaineIIIIII, Eugene R. Bleecker, Laura M. Paulin, Nadia N. Hansel, M. Bradley Drummond, Neil E. Alexis, Wayne H. Anderson, R. Graham Barr, Eugene R. Bleecker, Richard C. Boucher, Russell P. Bowler, Elizabeth E. Carretta, Stephanie A. Christenson, Alejandro P. Comellas, Christopher B. Cooper, David J. Couper, Gerard J. Criner, Ronald G. Crystal, Jeffrey L. Curtis, Claire M. Doerschuk, Mark T. Dransfield, Christine M. Freeman, MeiLan K. Han, Nadia N. Hansel, Annette T. Hastie, Eric A. Hoffman, Robert J. Kaner, Richard E. Kanner, Eric C. Kleerup, Jerry A. Krishnan, Lisa M. LaVange, Stephen C. Lazarus, Fernando J. Martinez, Deborah A. Meyers, Wendy C. Moore, John D. Newell, Laura Paulin, Stephen Peters, Elizabeth C. Oelsner, Wanda K. O’Neal, Victor E. Ortega, Robert Paine, Nirupama Putcha, Stephen I. Rennard, Donald P. Tashkin, Mary Beth Scholand, J. Michael Wells, Robert A. Wise, Prescott G. Woodruff, Lisa Postow & Thomas Croxton. (2018) Rural Residence and Chronic Obstructive Pulmonary Disease Exacerbations. Analysis of the SPIROMICS Cohort. Annals of the American Thoracic Society 15:7, pages 808-816.
Crossref
Crossref
Mona Bafadhel, Stefan Peterson, Miguel A De Blas, Peter M Calverley, Stephen I Rennard, Kai Richter & Malin Fagerås. (2018) Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials. The Lancet Respiratory Medicine 6:2, pages 117-126.
Crossref
Crossref
Alexandra Strassmann, Anja Frei, Sarah R. Haile, Gerben ter Riet & Milo A. Puhan. (2017) Commonly Used Patient-Reported Outcomes Do Not Improve Prediction of COPD Exacerbations. Chest 152:6, pages 1179-1187.
Crossref
Crossref
Sujee Lee, Xiang Zhong, Hyo Kyung Lee, Cong Zhao, Philip A. Bain, Tammy Kundinger, Craig Sommers, Christine Baker & Jingshan Li. (2017) Incentive-based optimal intervention policy to reduce hospital readmissions for COPD patients. Incentive-based optimal intervention policy to reduce hospital readmissions for COPD patients.
Martine Hoogendoorn, Talitha L. Feenstra, Yumi Asukai, Andrew H. Briggs, Sixten Borg, Roberto W. Dal Negro, Ryan N. Hansen, Sven-Arne Jansson, Reiner Leidl, Nancy Risebrough, Yevgeniy Samyshkin, Margarethe E. Wacker & Maureen P.M.H. Rutten-van Mölken. (2016) Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?. Value in Health 19:6, pages 800-810.
Crossref
Crossref
Rupert C Jones, David Price, Niels H Chavannes, Amanda J Lee, Michael E Hyland, Björn Ställberg, Karin Lisspers, Josefin Sundh, Thys van der Molen & Ioanna Tsiligianni. (2016) Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets. npj Primary Care Respiratory Medicine 26:1.
Crossref
Crossref
Christine R. Jenkins, Dirkje S. Postma, Antonio R. Anzueto, Barry J. Make, Stefan Peterson, Göran Eriksson & Peter M. Calverley. (2015) Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease. BMC Pulmonary Medicine 15:1.
Crossref
Crossref
Josep Montserrat-Capdevila, Pere Godoy, Josep Ramon Marsal, Ferran Barbé & Leonardo Galván. (2015) Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study. BMC Family Practice 16:1.
Crossref
Crossref